ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2022 American Transplant Congress

TOPIC: Clinical Science » Liver » 56 - Liver: Hepatocellular Carcinoma and Other Malignancies

  • Immune Checkpoints, Immune Cells, and MHC Expression in the Tumor Microenvironment of Resected Hepatocellular Carcinomas

    A. Baquerizo1, V. Vavinskaya2, S. Bagsic1, A. Rojas3, A. Mhoyan4, C. Frenette1, L. Sher5, M. Romero3, J. Fisher1, C. Marsch1, R. Schaffer1

  • Impacts Of Donor Gender On Recurrent Hepatocellular Carcinoma In Liver Transplant Donated After Brain Death

    T. Nakamura1, K. Sasaki2, T. Yamamoto1, S. Kimura1, L. Dageforde1, H. Yeh1, N. Elias1, T. Kawai1, J. F. Markmann1

  • Increased Regulatory T-cells in Tumor Microenvironment is Associated with Hepatocellular Carcinoma Differentiation in Patients Undergoing Liver Transplantation

    G. Orozco1, R. Gedaly2, L. Turcios2, F. Marti2

  • Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for T2 Hepatocellular Carcinoma and May Allow for Decreased Mortality

    C. Durkin1, T. Bittermann1, D. E. Schaubel2

  • Is Repeat Resection for Recurrent Intrahepatic Cholangiocarcinoma Warranted? Outcomes of an International Multicenter Analysis

    M. L. Holzner1, V. Mazzaferro2, M. Droz dit Busset2, L. Aldrighetti3, F. Ratti3, K. Hasegawa4, J. Arita4, G. Sapisochin5, P. Abreu5, W. Schoening6, N. Nevermann6, M. Schmelzle6, J. Pratschke6, S. Florman1, K. Halazun7, M. E. Schwartz1, P. Tabrizian1

  • Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: An Analysis of the European Liver Transplant Registry

    M. P. Claasen1, T. Ivanics2, J. N. IJzermans1, G. Sapisochin2, W. Polak1

  • Liver Transplantation for Patients with Fibrolamellar Hepatocellular Carcinoma: A Comprehensive Multicenter Analysis to Support Future Decision Making

    M. P. Claasen1, T. Ivanics1, W. G. Polak2, J. N. IJzermans2, G. Sapisochin1

  • Locoregional Therapy and Long-Term Post-Transplant Outcomes for HCC Liver Transplant Recipients

    T. Ishaque, S. R. Weeks, A. Kolarich, J. Ruck, J. Garonzik-Wang, D. Segev, A. Massie, B. King

  • Locoregional Therapy for Hepatocellular Carcinoma Decreases Liver Transplant Waitlist Dropout and Mortality

    S. Weeks, T. Ishaque, A. Massie, D. Segev, E. King

  • Nivolumab After Sorafenib Failure in Liver Recipients with HCC Recurrence

    J. Kwon

  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences